Brenda Thompson: Daily

George Kailas leverages a retail-tested signal library and a 'Flash Boys' alum to launch Aethon, a hedge fund aiming to demystify AI trading.

As federal mandates push to end decades of stagnation, one company's 'truly real-time' platform offers a foundational fix for drug development.

A U.S.-China partnership is testing a drug that could replace cataract surgery. The ZOC2017217 eye drop aims to reverse vision loss for millions.

Dr. Sydney C. Butts, a leading facial plastic surgeon, joins ENT & Allergy Associates, bringing world-class reconstructive and aesthetic care to Brooklyn.

NUBURU is launching a bold, premium-priced $38M offering to acquire Tekne, clear its books, and secure its NYSE listing in a high-stakes pivot to defense.

As Kayne Anderson BDC prepares its Q2 report, investors are watching for clues on credit quality and the resilience of its senior-secured loan strategy.

A $100K grant for military kids' education is just the start. See how CAPTRUST's employee-funded foundation is redefining corporate social responsibility.

The world's oldest crypto exchange raised £88k for a children's charity via celebrity golf. It’s more than a game—it’s a new strategy for social impact.

A new platform is betting on AI-generated dramas and an 80% creator payout. Can Lollipop's dual-content strategy redefine mobile entertainment and empower a new class?

With 32% growth and a new AI platform, Voxie is solving the franchise paradox: balancing corporate brand control with the local operator's need to drive results.

Weave's No. 1 ranking isn't just an award; it's a market signal that verified user satisfaction and practical AI are the new benchmarks for success.

A new deal to extract cobalt from a Finnish gold mine highlights a strategic shift to secure Europe's critical raw materials and reduce foreign dependency.

With its stock at an all-time high after a stellar Q1, all eyes are on Univest's upcoming Q2 report to see if its strategic execution can defy market pressures.

A multi-million dollar expansion in Midland is more than new walls. It's a tale of market foresight, deep community roots, and a 75-year manufacturing legacy.

As content demands soar, new AI tools from Krikey AI promise studio-level animation in minutes, solving the creator crunch but raising new questions.

After a successful FIFA World Cup debut, ADI Predictstreet is expanding. We explore how Gibraltar's regulatory gambit and blockchain tech are creating a new global forecasting tool.

A massive financing round for deupirfenidone isn't just about a potential new IPF drug; it's a masterclass in biotech strategy, validating a model that promises value for all.

Megan Thee Stallion's new unisex fragrance with Coty is more than a product launch; it's a masterclass in brand authenticity and market disruption.

Rentschler Biopharma appoints Dr. Torsten Woehr as CEO, a strategic move to deepen its core biologics focus after exiting cell and gene therapy.

A specialized China tech fund's triple-digit returns are turning heads. This isn't just a market anomaly; it's a sign of China's quiet rise as a force in the global semiconductor race.